EN
HI
Concord Biotech share price chart
Concord Biotech Share Key Metrics
Volume
55644.00
Market Cap
13140.84 CR
LTQ@LTP
1@1306.10
ATP
1298.93
Var Margin
20.35 %
Circuit Range
1004.9-1507.3
Delivery %
53.61 %
Value
7.23 CR
ASM/GSM
No
Market Lot
1
Summary
CONCORDBIO stock price is ₹1306.1 as of 29 Jul, 2026. The stock intraday movement has stayed between ₹1252.30 and ₹1315.90, while Concord Biotech share price 52 week high low is ₹987.00 & ₹1905.00.
In terms of trading activity, CONCORDBIO share price has recorded a volume of 55,644 shares. The Concord Biotech has a market cap of ₹104616204. The stock’s Average Traded Price (ATP) stands at ₹1298.93, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1306.10.
The Concord Biotech upper circuit limit is ₹1507.30 & The Concord Biotech lower circuit limit is ₹1004.90, with a Value of ₹7.23 CR. The Delivery Percentage for the day is 53.61%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Concord Biotech Fundamentals
P/E Ratio
50.29
P/B Ratio
6.5
Div. Yield
0.6
Sector P/E
63.98
Sector P/B
3.18
Sec. Div. Yield
0.52
Concord Biotech Resistance and Support
Pivot 1256.5
Resistance
First Resistance
1266.6
Second Resistance
1277.1
Third Resistance
1287.2
Support
First Support
1246
Second Support
1235.9
Third Support
1225.4
Concord Biotech Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Jul 29 2026 | 1263 | 1306.1 | 3.98% | 1315.9 | 1252.3 |
| Tue Jul 28 2026 | 1267 | 1256.09 | -0.02% | 1267 | 1246.4 |
| Mon Jul 27 2026 | 1255.19 | 1256.4 | 0.63% | 1275.3 | 1244.5 |
Concord Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Concord Biotech News
Concord Biotech Ltd - 543960 - Intimation Of Record Date And Book Closure Date
Concord Biotech has fixed July 24, 2026, as the Record Date for its final dividend for FY26. Shareholders as of this date will be eligible for the dividend, with payment by August 30, 2026, subject to AGM approval.
Jul 07 2026 17:30:40
Concord Biotech Ltd - 543960 - Business Responsibility and Sustainability Reporting (BRSR)
Concord Biotech filed its Business Responsibility and Sustainability Report for FY2025-26. The report provides a comprehensive overview of the company's environmental, social, and governance performance, policies, and commitments, ensuring transparency and compliance.
Jul 07 2026 16:26:46
Read More
Concord Biotech Management
| Name | Position |
|---|---|
| Sudhir Vaid | Chairman & Managing Director |
| Ankur Vaid | Joint Managing Director & CEO |
Concord Biotech Similar Stocks
Alembic Pharmaceuticals Ltd.
811.55
-7.30 (0.89%)
Jubilant Pharmova Ltd.
981.95
18.50 (1.92%)
Dr. Agarwal's Health Care Ltd.
493.20
0.10 (0.02%)
Rainbow Children's Medicare Ltd.
1483.10
13.60 (0.93%)
Vijaya Diagnostic Centre Ltd.
1362.00
2.90 (0.21%)
CORONA Remedies Ltd.
2116.70
47.00 (2.27%)
Alivus Life Sciences Ltd.
1121.20
16.50 (1.49%)
Shilpa Medicare Ltd.
609.30
4.10 (0.68%)
Park Medi World Ltd.
280.70
3.05 (1.10%)
Metropolis Healthcare Ltd.
589.45
3.95 (0.67%)
Concord Biotech FAQs
The Buying Price of Concord Biotech share is 1306.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Concord Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Concord Biotech shares is 50.29. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Concord Biotech shares is 6.5. Useful to assess the stock's value relative to its book value.
To assess Concord Biotech’s valuation compare Sector P/E, P/B which are 63.98 & 3.18 with sector averages, along with growth rates and financial metrics.
The Market Cap of Concord Biotech is 13140.84 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Concord Biotech share price is 1905.00 & 987.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Concord Biotech belongs to the Healthcare sector.
Open a FREE Demat Account in 5 Mins.
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in CONCORDBIO
Or Download Choice FinX App
Invest in CONCORDBIO
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade